WBAL2 天
FDA approves first new drug for schizophrenia in more than 30 years
The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...
STAT3 天
FDA introduces plan to assess safety of common chemicals added to food
After years of pressure, the FDA said it is strengthening its review of many chemical additives used to enhance color, ...
The Washington Post on MSN3 天
FDA approves a novel drug for schizophrenia, a potential ‘game changer’
The U.S. Food and Drug Administration late Thursday approved a new kind of drug to treat schizophrenia, a breakthrough after ...
You can join FDA’s meeting on food chemical safety
How the U.S. and the FDA handle the nation's food supply and packaging has been in the spotlight more lately since former ...
FDA approves new type of schizophrenia drug
The U.S. Food and Drug Administration (FDA) on Friday approved a new drug used for treating schizophrenia in adults, ...
tag248 天
FDA approves a first-of-a-kind flu vaccine in the form of a nasal spray!
In a first, the Food and Drug Administration on Friday approved AstraZeneca's FluMist, a nasal spray flu vaccine that anyone ...
Medindia3 天
FDA Approves Drug with New Mechanism of Action for Treatment of Schizophrenia
Today, the U.S. Food and Drug Administration approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults. It is the first antipsychotic drug ...
Bisnow6 天
Silver Spring Passive House Development Lands $303M To Start Construction
The Hillandale Gateway project is a joint effort from the Housing Opportunities Commission of Montgomery County, The Duffie ...
FDA Issues Draft Guidance on Conducting Multiregional Clinical Trials in Oncology
Today, the U.S. Food and Drug Administration issued a draft guidance for industry that, when finalized, will provide sponsors with recommendations for conducting multiregional clinical trials (MRCT) ...
wtvr2 天
FDA approves first new medication to treat schizophrenia in more than 30 years
People with schizophrenia will soon have a new treatment option after the FDA approved its first new treatment for the mental ...
medtechdive3 天
FDA proposes reclassifying hepatitis B assays
The FDA plans to move the assays from higher-risk class III devices to class II, making them eligible for the 510(k) pathway.